Document is current
Any future updates will be listed below
-
Authors
Spurr, Liam F.
Pitroda, Sean P.
-
Funding
Funding for this research was provided by:
John D. Arnold, MD Scientific Research Prize
Ludwig Cancer Research Foundation
LUNGevity Foundation
University of Chicago Comprehensive Cancer Center
American Lung Association
Falk Medical Research Trust
- License Information
-
More Information
Article History
Received: 7 April 2024
Accepted: 26 June 2024
First Online: 21 August 2024
Competing interests
: L.F.S. and S.P.P. have filed patents related to the use of tumor aneuploidy as a predictor of response to radiotherapy and immunotherapy. S.P.P. holds other patents outside the submitted work.
